Open Nav

Dr. Mintz brings a wealth of experience to his role as Chief Medical Officer at Verax. He is former president of the AABB who served as a tenured professor of Pathology and Medicine at the University of Virginia as well as Vice Chair of Pathology.

He also served on the AABB's board of directors for nine years, and chaired and was a member of numerous AABB committees. Most recently, Dr. Mintz served as Director, Division of Hematology Clinical Review, Office of Blood Research and Review, Center for Biologics Evaluation and Research of the U.S. Food and Drug Administration.


White Papers & Commentaries

  • Implementing 7 Day Platelet Dating with the Platelet PGD® Test

    Hospitals and blood centers across the country are implementing 7-day platelet dating with the Platelet PGD Test in order to improve platelet availability, inventory management, and reduce wastage caused by outdating. This complete review of the topic offers a detailed how-to guide, resources and insights drawn from institutions' experiences as well as a review of the support available to aid in going live with 7-day platelet dating.
    Read the White Paper
  • Will pathogen reduction of blood components harm more people than it helps in developed countries?

    This recently published article in the journal Transfusion takes a critical look at the implications of pathogen reduced blood components and their potential impact on massively transfused patients. A review of the authors methodology and conclusions raises significant concerns regarding the implications for the broad use of pathogen reduced platelets and plasma with trauma and other massively transfused patient populations.
    Read the Article Review
  • FDA Draft Guidance: Recommendations for addressing bacterial contamination risk in platelets and pathway for immediate extension of platelet dating to 7 days

    The FDA recently published draft guidance outlining its recommendations for addressing the risk of bacterial contamination in platelets as well as outlining the currently available pathway to 7 day platelet dating. This review summarizes the salient issues in the guidance and offers suggestions for hospital and blood center decision makers to consider as they evaluate the implications of this guidance for their facilities.
    Read the White Paper
  • The Inadequacy Of Passive Surveillance To Detect Septic Transfusion Reactions From Platelet Transfusion

    Septic transfusion reactions resulting from the transfusion of bacterially contaminated platelet components are a potentially fatal hazard of platelet transfusion. A review of the recent literature reveals just how ineffective passive surveillance is at recognizing when they occur and points the way towards active surveillance through testing as a better approach.
    Read the White Paper
  • Safety and Efficacy of Seven Day Platelets

    Recent FDA product approvals and a pathway outlined in draft FDA guidance have allowed the reintroduction of seven day platelet dating in the United States. But just how safe and effective are seven day platelets?  A review of published in vitro and in vivo studies reveals the current consensus.
    Read the White Paper

Have a question or comment? Click here to contact me directly.

Learn more about

"I'm excited to work at Verax because the company shares my passion for patient safety and best transfusion practices. I'll use this blog to express my thoughts and views about current topics in transfusion medicine and how they may impact your transfusion service or blood bank."

- Paul D. Mintz, MD

Hot Topics

CMS Modifies Permanent P-Code Allowing Outpatient Hospital Billing of the Verax PGD® Test
Learn More

FDA advises testing for Zika virus in all donated blood and blood components in the US
Learn More

Congressional Representatives call for broad Zika blood screening citing a cost of less than $10 per donor
Learn More

Major new publication of note: "Will pathogen reduction of blood components harm more people than it helps in developed countries?"
Learn More

First blood center in Texas initiates routine blood donor screening for Zika virus with new test under IND
Learn More

7 Day platelet dating added to 30th Edition of the AABB Standards for Blood Banks and Transfusion Services
Learn More

New Draft FDA Guidance recommends secondary testing with rapid tests and Safety Measure testing for 7-day dating
Learn More